APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cobamamide API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cobamamide API Industry Growth and Trends Forecast to 2032

23 December 202594 pages

Choose your research edition.

Industry ResearchCobamamide API Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Cobamamide API Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Cobamamide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cobamamide API Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cobamamide API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Cobamamide API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cobamamide API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cobamamide API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cobamamide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cobamamide API include HTBA, Interquim, Ningxia Kingvit Pharmaceutical, China Pharmaceutical Holding Group and Hebei Yuxing Bio-Engineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cobamamide API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cobamamide API market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cobamamide API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cobamamide API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cobamamide API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cobamamide API Market by Company

HTBA

Interquim

Ningxia Kingvit Pharmaceutical

China Pharmaceutical Holding Group

Hebei Yuxing Bio-Engineering

Cobamamide API Segment by Type

Purity≥98%

Purity<98%

Cobamamide API Segment by Application

Oral Formulation

Injectable Formulation

Cobamamide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cobamamide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cobamamide API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cobamamide API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity≥98% Table 2. Major Company of Purity<98% Table 3. Global Cobamamide API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cobamamide API Sales by Type (2021-2026) & (kg) Table 5. Global Cobamamide API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cobamamide API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cobamamide API Sales Market Share in Value by Type (2021-2026) Table 8. Global Cobamamide API Price by Type (2021-2026) & (USD/kg) Table 9. Global Cobamamide API Sales by Type (2027-2032) & (kg) Table 10. Global Cobamamide API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cobamamide API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cobamamide API Sales Market Share in Value by Type (2027-2032) Table 13. Global Cobamamide API Price by Type (2027-2032) & (USD/kg) Table 14. North America Cobamamide API Sales by Type (2021-2026) & (kg) Table 15. North America Cobamamide API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cobamamide API Sales by Type (2021-2026) & (kg) Table 17. Europe Cobamamide API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cobamamide API Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Cobamamide API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cobamamide API Sales by Type (2021-2026) & (kg) Table 21. Latin America Cobamamide API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cobamamide API Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Cobamamide API Sales by Type (2021-2026) & (US$ Million) Table 24. Cobamamide API Industry Trends Table 25. Cobamamide API Industry Drivers Table 26. Cobamamide API Industry Opportunities and Challenges Table 27. Cobamamide API Industry Restraints Table 28. Global Cobamamide API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cobamamide API Revenue Market Share by Company (2021-2026) Table 30. Global Cobamamide API Sales by Company (2021-2026) & (kg) Table 31. Global Cobamamide API Sales Share by Company (2021-2026) Table 32. Global Cobamamide API Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Cobamamide API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cobamamide API Major Company Production Sites and Headquarters Table 35. Global Cobamamide API Company, Product Type & Application Table 36. Global Cobamamide API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cobamamide API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cobamamide API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cobamamide API Sales by Region (2021-2026) & (kg) Table 41. Global Cobamamide API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cobamamide API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cobamamide API Sales Market Share in Value by Region (2021-2026) Table 44. Global Cobamamide API Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Cobamamide API Sales by Region (2027-2032) & (kg) Table 46. Global Cobamamide API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cobamamide API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cobamamide API Sales Market Share in Value by Region (2027-2032) Table 49. Global Cobamamide API Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Cobamamide API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cobamamide API Sales by Application (2021-2026) & (kg) Table 52. Global Cobamamide API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cobamamide API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cobamamide API Sales Market Share in Value by Application (2021-2026) Table 55. Global Cobamamide API Price by Application (2021-2026) & (USD/kg) Table 56. Global Cobamamide API Sales by Application (2027-2032) & (kg) Table 57. Global Cobamamide API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cobamamide API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cobamamide API Sales Market Share in Value by Application (2027-2032) Table 60. Global Cobamamide API Price by Application (2027-2032) & (USD/kg) Table 61. North America Cobamamide API Sales by Application (2021-2026) & (kg) Table 62. North America Cobamamide API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cobamamide API Sales by Application (2021-2026) & (kg) Table 64. Europe Cobamamide API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cobamamide API Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Cobamamide API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cobamamide API Sales by Application (2021-2026) & (kg) Table 68. Latin America Cobamamide API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cobamamide API Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Cobamamide API Sales by Application (2021-2026) & (US$ Million) Table 71. HTBA Company Information Table 72. HTBA Business Overview Table 73. HTBA Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. HTBA Cobamamide API Product Portfolio Table 75. HTBA Recent Development Table 76. Interquim Company Information Table 77. Interquim Business Overview Table 78. Interquim Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Interquim Cobamamide API Product Portfolio Table 80. Interquim Recent Development Table 81. Ningxia Kingvit Pharmaceutical Company Information Table 82. Ningxia Kingvit Pharmaceutical Business Overview Table 83. Ningxia Kingvit Pharmaceutical Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Ningxia Kingvit Pharmaceutical Cobamamide API Product Portfolio Table 85. Ningxia Kingvit Pharmaceutical Recent Development Table 86. China Pharmaceutical Holding Group Company Information Table 87. China Pharmaceutical Holding Group Business Overview Table 88. China Pharmaceutical Holding Group Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. China Pharmaceutical Holding Group Cobamamide API Product Portfolio Table 90. China Pharmaceutical Holding Group Recent Development Table 91. Hebei Yuxing Bio-Engineering Company Information Table 92. Hebei Yuxing Bio-Engineering Business Overview Table 93. Hebei Yuxing Bio-Engineering Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Hebei Yuxing Bio-Engineering Cobamamide API Product Portfolio Table 95. Hebei Yuxing Bio-Engineering Recent Development Table 96. North America Cobamamide API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 97. North America Cobamamide API Sales by Country (2021-2026) & (kg) Table 98. North America Cobamamide API Sales Market Share by Country (2021-2026) Table 99. North America Cobamamide API Sales Forecast by Country (2027-2032) & (kg) Table 100. North America Cobamamide API Sales Market Share Forecast by Country (2027-2032) Table 101. North America Cobamamide API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Cobamamide API Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Cobamamide API Market Share by Country (2021-2026) Table 104. North America Cobamamide API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Cobamamide API Market Share Forecast by Country (2027-2032) Table 106. Europe Cobamamide API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 107. Europe Cobamamide API Sales by Country (2021-2026) & (kg) Table 108. Europe Cobamamide API Sales Market Share by Country (2021-2026) Table 109. Europe Cobamamide API Sales Forecast by Country (2027-2032) & (kg) Table 110. Europe Cobamamide API Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Cobamamide API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Cobamamide API Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Cobamamide API Market Share by Country (2021-2026) Table 114. Europe Cobamamide API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Cobamamide API Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Cobamamide API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Cobamamide API Sales by Country (2021-2026) & (kg) Table 118. Asia-Pacific Cobamamide API Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Cobamamide API Sales Forecast by Country (2027-2032) & (kg) Table 120. Asia-Pacific Cobamamide API Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Cobamamide API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Cobamamide API Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Cobamamide API Market Share by Country (2021-2026) Table 124. Asia-Pacific Cobamamide API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Cobamamide API Market Share Forecast by Country (2027-2032) Table 126. Latin America Cobamamide API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 127. Latin America Cobamamide API Sales by Country (2021-2026) & (kg) Table 128. Latin America Cobamamide API Sales Market Share by Country (2021-2026) Table 129. Latin America Cobamamide API Sales Forecast by Country (2027-2032) & (kg) Table 130. Latin America Cobamamide API Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Cobamamide API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Cobamamide API Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Cobamamide API Market Share by Country (2021-2026) Table 134. Latin America Cobamamide API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Cobamamide API Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Cobamamide API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Cobamamide API Sales by Country (2021-2026) & (kg) Table 138. Middle East and Africa Cobamamide API Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Cobamamide API Sales Forecast by Country (2027-2032) & (kg) Table 140. Middle East and Africa Cobamamide API Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Cobamamide API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Cobamamide API Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Cobamamide API Market Share by Country (2021-2026) Table 144. Middle East and Africa Cobamamide API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Cobamamide API Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Cobamamide API Distributors List Table 149. Cobamamide API Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Cobamamide API Image Figure 2. Global Cobamamide API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cobamamide API Market Size (2021-2032) & (US$ Million) Figure 4. Global Cobamamide API Sales (2021-2032) & (kg) Figure 5. Purity≥98% Image Figure 6. Global Purity≥98% Sales YoY Growth (2021-2032) & (kg) Figure 7. Purity<98% Image Figure 8. Global Purity<98% Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Cobamamide API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cobamamide API Market Share by Type 2025 VS 2032 Figure 11. North America Cobamamide API Sales Market Share in Volume by Type in 2025 Figure 12. North America Cobamamide API Sales Market Share in Value by Type in 2025 Figure 13. Europe Cobamamide API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cobamamide API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cobamamide API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cobamamide API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cobamamide API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cobamamide API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cobamamide API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cobamamide API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cobamamide API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oral Formulation Image Figure 24. Global Oral Formulation Sales YoY Growth (2021-2032) & (kg) Figure 25. Injectable Formulation Image Figure 26. Global Injectable Formulation Sales YoY Growth (2021-2032) & (kg) Figure 27. Global Cobamamide API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cobamamide API Market Share by Application 2025 VS 2032 Figure 29. North America Cobamamide API Sales Market Share in Volume by Application in 2025 Figure 30. North America Cobamamide API Sales Market Share in Value by Application in 2025 Figure 31. Europe Cobamamide API Sales Market Share in Volume by Application in 2025 Figure 32. Europe Cobamamide API Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Cobamamide API Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Cobamamide API Sales Market Share in Value by Application in 2025 Figure 35. Latin America Cobamamide API Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Cobamamide API Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Cobamamide API Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Cobamamide API Sales Market Share in Value by Application in 2025 Figure 39. North America Cobamamide API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 40. North America Cobamamide API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Cobamamide API Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cobamamide API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. Europe Cobamamide API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Cobamamide API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Cobamamide API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Asia-Pacific Cobamamide API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Cobamamide API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Cobamamide API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Latin America Cobamamide API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cobamamide API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Cobamamide API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Middle East and Africa Cobamamide API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Cobamamide API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Cobamamide API Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Cobamamide API Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥98%
  • Purity<98%
Applications
  • Oral Formulation
  • Injectable Formulation
Companies covered
  • HTBA
  • Interquim
  • Ningxia Kingvit Pharmaceutical
  • China Pharmaceutical Holding Group
  • Hebei Yuxing Bio-Engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cobamamide API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cobamamide API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cobamamide API Market by Type
  6. 1.3.1 Purity≥98%
  7. 1.3.2 Purity<98%
  8. 1.4 Global Cobamamide API Market Size by Type
  9. 1.4.1 Global Cobamamide API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cobamamide API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cobamamide API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cobamamide API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cobamamide API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cobamamide API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cobamamide API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cobamamide API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cobamamide API Industry Trends
  2. 2.2 Cobamamide API Industry Drivers
  3. 2.3 Cobamamide API Industry Opportunities and Challenges
  4. 2.4 Cobamamide API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cobamamide API Revenue (2021-2026)
  2. 3.2 Global Top Players by Cobamamide API Sales (2021-2026)
  3. 3.3 Global Top Players by Cobamamide API Price (2021-2026)
  4. 3.4 Global Cobamamide API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cobamamide API Major Company Production Sites & Headquarters
  6. 3.6 Global Cobamamide API Company, Product Type & Application
  7. 3.7 Global Cobamamide API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cobamamide API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cobamamide API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cobamamide API Tier 1, Tier 2, and Tier 3
4 Cobamamide API Regional Status and Outlook
  1. 4.1 Global Cobamamide API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cobamamide API Historic Market Size by Region
  3. 4.2.1 Global Cobamamide API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cobamamide API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cobamamide API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cobamamide API Forecasted Market Size by Region
  7. 4.3.1 Global Cobamamide API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cobamamide API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cobamamide API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cobamamide API by Application
  1. 5.1 Cobamamide API Market by Application
  2. 5.1.1 Oral Formulation
  3. 5.1.2 Injectable Formulation
  4. 5.2 Global Cobamamide API Market Size by Application
  5. 5.2.1 Global Cobamamide API Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cobamamide API Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cobamamide API Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cobamamide API Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cobamamide API Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cobamamide API Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cobamamide API Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cobamamide API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HTBA
  2. 6.1.1 HTBA Company Information
  3. 6.1.2 HTBA Business Overview
  4. 6.1.3 HTBA Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HTBA Cobamamide API Product Portfolio
  6. 6.1.5 HTBA Recent Developments
  7. 6.2 Interquim
  8. 6.2.1 Interquim Company Information
  9. 6.2.2 Interquim Business Overview
  10. 6.2.3 Interquim Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Interquim Cobamamide API Product Portfolio
  12. 6.2.5 Interquim Recent Developments
  13. 6.3 Ningxia Kingvit Pharmaceutical
  14. 6.3.1 Ningxia Kingvit Pharmaceutical Company Information
  15. 6.3.2 Ningxia Kingvit Pharmaceutical Business Overview
  16. 6.3.3 Ningxia Kingvit Pharmaceutical Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ningxia Kingvit Pharmaceutical Cobamamide API Product Portfolio
  18. 6.3.5 Ningxia Kingvit Pharmaceutical Recent Developments
  19. 6.4 China Pharmaceutical Holding Group
  20. 6.4.1 China Pharmaceutical Holding Group Company Information
  21. 6.4.2 China Pharmaceutical Holding Group Business Overview
  22. 6.4.3 China Pharmaceutical Holding Group Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 China Pharmaceutical Holding Group Cobamamide API Product Portfolio
  24. 6.4.5 China Pharmaceutical Holding Group Recent Developments
  25. 6.5 Hebei Yuxing Bio-Engineering
  26. 6.5.1 Hebei Yuxing Bio-Engineering Company Information
  27. 6.5.2 Hebei Yuxing Bio-Engineering Business Overview
  28. 6.5.3 Hebei Yuxing Bio-Engineering Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hebei Yuxing Bio-Engineering Cobamamide API Product Portfolio
  30. 6.5.5 Hebei Yuxing Bio-Engineering Recent Developments
7 North America by Country
  1. 7.1 North America Cobamamide API Sales by Country
  2. 7.1.1 North America Cobamamide API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cobamamide API Sales by Country (2021-2026)
  4. 7.1.3 North America Cobamamide API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cobamamide API Market Size by Country
  6. 7.2.1 North America Cobamamide API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cobamamide API Market Size by Country (2021-2026)
  8. 7.2.3 North America Cobamamide API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cobamamide API Sales by Country
  2. 8.1.1 Europe Cobamamide API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cobamamide API Sales by Country (2021-2026)
  4. 8.1.3 Europe Cobamamide API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cobamamide API Market Size by Country
  6. 8.2.1 Europe Cobamamide API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cobamamide API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cobamamide API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cobamamide API Sales by Country
  2. 9.1.1 Asia-Pacific Cobamamide API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cobamamide API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cobamamide API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cobamamide API Market Size by Country
  6. 9.2.1 Asia-Pacific Cobamamide API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cobamamide API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cobamamide API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cobamamide API Sales by Country
  2. 10.1.1 South America Cobamamide API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cobamamide API Sales by Country (2021-2026)
  4. 10.1.3 South America Cobamamide API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cobamamide API Market Size by Country
  6. 10.2.1 South America Cobamamide API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cobamamide API Market Size by Country (2021-2026)
  8. 10.2.3 South America Cobamamide API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cobamamide API Sales by Country
  2. 11.1.1 Middle East and Africa Cobamamide API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cobamamide API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cobamamide API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cobamamide API Market Size by Country
  6. 11.2.1 Middle East and Africa Cobamamide API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cobamamide API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cobamamide API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cobamamide API Value Chain Analysis
  2. 12.1.1 Cobamamide API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cobamamide API Production Mode & Process
  7. 12.2 Cobamamide API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cobamamide API Distributors
  10. 12.2.3 Cobamamide API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst